FdaApplication
NDA 050072
Identifiers
- fda_app_no: NDA050072
Properties
| Property | Value |
|---|---|
| applicant_name | WYETH AYERST LABORATORIES |
| application_type | NDA |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PENBRITIN-S | AMPICILLIN SODIUM | EQ 4GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| PENBRITIN-S | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| PENBRITIN-S | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| PENBRITIN-S | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| PENBRITIN-S | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| PENBRITIN-S | AMPICILLIN SODIUM | EQ 125MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
6 products